查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1860485

抗菌成分市場：全球預測（2025-2032 年），按應用、類型、劑型、功能和來源分類

Antimicrobial Ingredients Market by Application, Type, Form, Function, Source - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，抗菌成分市場將成長至 81.1 億美元，複合年成長率為 7.06%。

關鍵市場統計數據
基準年 2024 47億美元
預計年份：2025年 50.4億美元
預測年份 2032 81.1億美元
複合年成長率 (%) 7.06%

簡要介紹不斷發展的抗菌成分領域以及產品開發人員和採購經理需要考慮的策略因素

由於監管要求的變化、消費者偏好的轉變以及活性成分和遞送系統技術的進步，抗菌成分領域正在迅速發展。本執行摘要概述了與產品開發人員、配方師、採購團隊和法規事務負責人最相關的趨勢。它揭示了新興的天然替代品、改進的合成化學方法和創新配方如何重塑從醫療和個人護理到農業和水處理等應用領域。

技術進步的融合、法規結構的收緊以及終端用戶需求的改變，正在重塑競爭與創新的格局。

抗菌成分產業正經歷技術、法規和需求的變革，從而改變競爭和創新的格局。天然萃取物純化技術的進步、用於標靶作用的改良有機酸以及新型銀基遞送系統的出現，使配方師能夠在降低毒性風險的同時，獲得更廣譜的抗菌頻譜。同時，包封技術、緩釋性粉末和凝膠流變學的改進，也為塗層和醫療設備介面提供持續保護提供了更多可能性。

檢驗了近期美國關稅如何重塑採購決策、供應商策略和供應鏈彈性規劃。

美國近期採取的關稅措施及相關貿易政策調整，為全球抗菌成分供應鏈和籌資策略帶來了新的複雜性。對某些類別的化學中間體和成品活性成分提高進口關稅，導致到岸成本上升，促使買家重新評估其籌資策略。同時，為了降低單一國家風險，企業更加重視近岸外包和多源採購。這些商業性應對措施導致供應商合約重新評估、前置作業時間緩衝期延長，並在某些情況下加快了國內生產投資。

透過對應用、化學成分、製劑形式、功能和原料來源進行全面的細分分析，指導配方和供應鏈策略。

細分市場分析揭示了不同應用、成分類型、製劑形式、功能和成分來源所帶來的獨特需求模式和技術要求，這些因素共同定義了策略性產品路徑。在農業領域，飼料添加劑優先考慮腸道耐受性，而作物保護活性成分則需要環境持久性和對非目標物種的安全性，二者的需求截然不同。在食品飲料領域，食品保藏化學品優先考慮保存期限，而表面消毒劑則必須保持與食品接觸的兼容性，二者的需求也截然不同。在醫療保健領域，醫院消毒劑需要高效性，而醫療設備被覆劑則需要生物相容性黏附性和緩釋性，二者的需求也截然不同。在家用清潔劑領域，洗衣添加劑注重織物安全性，而表面清潔劑則力求達到零殘留性能，二者的需求也截然不同。個人護理應用涵蓋抗菌皂、除臭劑和口腔清潔用品等，每種產品都有其獨特的感官和監管限制。水處理需求因飲用水應用（需要微量安全）和污水處理應用（優先考慮對微生物負荷的廣泛抵抗力）而異。

區域趨勢和策略要務正在影響全球的監管合規、供應鏈設計和商業化路徑。

區域趨勢正在影響全球抗菌成分市場的需求結構、監管重點和創新生態系統。在美洲，強勁的醫療保健機構需求和成熟的消費市場（追求永續性認證和監管透明度）是推動商業活動的主要動力。在此環境下，供應商重視檢驗的安全資料和可擴展的生產方法，而買家則尋求擁有完善的品管系統和本地化生產的供應商，以降低物流風險。

抗菌成分領域主要企業的關鍵屬性和策略舉措：從配方創新到供應鏈韌性和卓越的監管能力。

在抗菌成分領域，產業領先地位越來越依賴技術差異化、監管專業知識和靈活生產能力的結合。主要企業正在投資先進的配方平台，提升天然萃取物標準化能力，並擴大包封和緩釋技術的規模，以實現持久的抗菌性能。這些投資通常輔以與契約製造和專業配方商的策略聯盟，以彌補產能缺口，並加速新型活性成分的市場化進程。

為領導者提供實用建議，幫助他們協調創新、監管準備和供應鏈策略，以加速商業化並增強韌性。

行業領導者應採取多管齊下的方法，將研發重點與監管前瞻性和商業性靈活性相結合，以抓住新的機會。首先，優先發展兼顧療效、安全性和環境效益的化學和遞送系統，將降低下游配方調整的風險，並有助於產品獲得更廣泛的市場認可。其次，投資供應商多元化和近岸外包，能夠更快地回應關鍵應用，同時降低受政策主導的貿易中斷影響的風險。第三，建立強大的監管情報能力並儘早與監管機構溝通，可以縮短核准週期，避免合規障礙。

調查方法：結合一手訪談、技術文獻綜合與供應鏈分析，以確保基於實務者觀點的嚴謹見解。

本研究採用多層次調查方法進行綜合分析，結合一手訪談、技術文獻綜述及跨產業趨勢分析，以全面了解抗菌成分的發展趨勢。一手資料透過對製劑科學家、採購主管、法規事務專業人員和生產負責人進行結構化訪談收集，旨在深入了解研發重點、採購限制和合規實踐等方面的實際問題。這些定性資料與權威技術出版物、安全性評估和監管檢驗進行三角驗證，以確保事實準確性和技術深度。

總結報告整合了技術、監管和供應鏈等主題，概述了實現持續競爭優勢的策略要務。

摘要，抗菌成分產業正處於轉折點，技術創新、不斷變化的法規以及地緣政治因素共同塑造產品開發和籌資策略。優先考慮安全和永續化學技術、實現供應鏈多元化並加強跨職能團隊協作的企業，將更有能力滿足不斷變化的終端用戶需求。對包封技術、緩釋性和標準化天然萃取物生產的策略性投資將有助於企業獲得競爭優勢，而與監管機構的密切合作則能縮短關鍵應用領域的合規時間。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 化妝品配方中對用於對抗皮膚病原體的多功能抗菌肽的需求不斷成長
  • 將銀奈米顆粒整合到先進的傷口敷料中，以實現持續的抗菌功效
  • 在食品包裝中利用天然植物來源的抗菌劑取代合成防腐劑
  • 開發用於高接觸醫療器材與設備的抗生物膜抗菌塗層
  • 新的監管趨勢推動了非三唑類抗真菌藥物在家庭清潔產品中的應用
  • 創新酵素基抗菌解決方案，對抗農業中的抗生素抗藥性

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 抗菌成分市場：依應用領域分類

  • 農業
    • 飼料添加劑
    • 作物保護
  • 食品/飲料
    • 食品保藏
    • 表面衛生管理
  • 衛生保健
    • 醫院消毒劑
    • 醫療設備塗層
  • 家用清潔劑
    • 洗衣添加物
    • 表面清潔劑
  • 個人護理
    • 抗菌皂
    • 除臭劑
    • 口腔清潔用品
  • 水處理
    • 飲用水
    • 污水處理

第9章 抗菌成分市場：依類型分類

  • 天然萃取物
    • 精油
      • 茶樹油
      • 百里香油
    • 植物萃取物
      • 葡萄柚籽萃取物
  • 有機酸
    • 苯甲酸
    • 丙酸
    • 山梨酸
  • 酚類化合物
    • 鄰苯基苯酚
    • 三氯生
  • 季銨化合物
    • 苯扎氯銨
    • 二癸基二甲基氯化銨
  • 銀型
    • 膠體銀
    • 銀色沸石

第10章 抗菌成分市場：依劑型分類

  • 形式
    • 氣霧泡沫
    • 非氣霧劑泡沫
  • 凝膠
    • 標準凝膠
    • 觸變凝膠
  • 液體
    • 水溶液
    • 乳液
  • 粉末
    • 顆粒
    • 微膠囊

第11章 抗菌成分市場：依功能分類

  • 塗層
    • 工業塗料
    • 醫療設備塗層
  • 消毒劑
    • 器械消毒劑
    • 表面消毒劑
  • 防腐劑
    • 化妝品防腐劑
    • 食品防腐劑
  • 消毒劑
    • 乾洗手劑
    • 表面消毒劑

第12章 抗菌成分市場：依原料分類

  • 自然的
    • 微生物發酵
      • 細菌素
      • 酵素萃取物
    • 植物來源
  • 合成
    • 生物基合成
    • 石油化工衍生性商品

第13章：各地區抗菌成分市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 抗菌成分市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國抗菌成分市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Lonza Group AG
    • BASF SE
    • Dow Inc.
    • Evonik Industries AG
    • Solvay SA
    • DuPont de Nemours, Inc.
    • LANXESS AG
    • Clariant AG
    • Arkema SA
    • Ashland Global Holdings Inc.
Product Code: MRR-69324464D0CE

The Antimicrobial Ingredients Market is projected to grow by USD 8.11 billion at a CAGR of 7.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.70 billion
Estimated Year [2025] USD 5.04 billion
Forecast Year [2032] USD 8.11 billion
CAGR (%) 7.06%

Concise introduction framing the evolving antimicrobial ingredients landscape and the strategic considerations for product developers and procurement leaders

The antimicrobial ingredients landscape is undergoing rapid evolution driven by shifting regulatory expectations, changing consumer preferences, and technological advances in active chemistries and delivery systems. This executive summary synthesizes the most pertinent developments affecting product developers, formulators, procurement teams, and regulatory affairs professionals. It highlights how emerging natural alternatives, refined synthetic chemistries, and novel formulation formats are reshaping applications from healthcare and personal care to agriculture and water treatment.

In this context, stakeholders must navigate an increasingly complex intersection of functionality, safety, and sustainability. Across sectors, there is growing emphasis on compatibility with sensitive substrates, non-toxic residue profiles, and lifecycle considerations that influence procurement and development decisions. To facilitate decision-making, this analysis distills strategic inflections, regulatory headwinds, and actionable segmentation insights that equip leaders to prioritize investments, adapt formulations, and strengthen supply chain resilience. The goal is to provide a clear, concise briefing that frames opportunities and responses without prescriptive numeric projections, so organizations can apply findings directly to their operational and strategic imperatives.

How converging technological advances, stricter regulatory frameworks, and changing end-use demands are reshaping competitive dynamics and innovation pathways

The antimicrobial ingredients sector is seeing transformative shifts across technology, regulation, and demand that are altering competitive dynamics and innovation pathways. Advances in natural extract purification, the refinement of organic acids for targeted efficacy, and new silver-based delivery systems are enabling formulators to achieve broader antimicrobial spectra while reducing toxicological concerns. At the same time, improvements in encapsulation, controlled-release powders, and gel rheology are expanding functional possibilities for long-lasting protection in coatings and medical device interfaces.

Regulatory landscapes are tightening in many jurisdictions, prompting manufacturers to reassess legacy actives and accelerate reformulation programs. Moreover, cross-sector convergence is intensifying; innovations developed for healthcare applications are migrating into personal care and household cleaners, and agricultural uses are borrowing preservation technologies from food safety science. As a result, strategic partnerships between ingredient suppliers, contract manufacturers, and application specialists are becoming more prevalent to bridge technical expertise and speed-to-market. Collectively, these shifts are creating both disruption and opportunity, and organizations that align R&D, regulatory foresight, and commercial strategy will be best positioned to capitalize on the next wave of demand.

Examination of how recent tariff measures in the United States have reshaped sourcing decisions, supplier strategies, and supply chain resilience planning

Recent tariff actions and associated trade policy shifts in the United States have introduced new layers of complexity for global supply chains and procurement strategies in antimicrobial ingredients. Increased import duties on certain classes of chemical intermediates and finished actives have raised landed costs and prompted buyers to revisit sourcing strategies, with a parallel focus on nearshoring and multi-sourcing to mitigate exposure to single-country risks. These commercial responses have led to a re-evaluation of supplier contracts, longer lead-time buffers, and in some instances the acceleration of domestic manufacturing investments.

Beyond direct cost effects, tariffs have influenced supplier behavior: some manufacturers are absorbing margin impacts to retain market access while others are redirecting exports to more favorable markets. The policy environment has also catalyzed an uptick in qualification of alternate chemistries and locally produced natural extracts that reduce reliance on tariff-affected imports. For companies integrating antimicrobial ingredients into critical applications, these dynamics emphasize the need for more robust scenario planning, expanded supplier audits, and contractual flexibility to manage price volatility and compliance obligations. In short, the tariff landscape is a strategic factor that now informs sourcing, innovation prioritization, and capital allocation decisions across the value chain.

Comprehensive segmentation insights across applications, chemistries, formulation formats, functional roles, and source origins to guide formulation and supply chain strategies

Segmentation analysis reveals nuanced demand patterns and technical requirements across applications, ingredient types, formulation forms, functional roles, and source origins that together define strategic product pathways. In agriculture, need profiles diverge between animal feed additives that prioritize gut-targeted tolerability and crop protection actives that demand environmental persistence and safety for non-target species; the food and beverage domain separates food preservation chemistries focused on shelf life from surface sanitation agents that must maintain food-contact compatibility. Healthcare applications bifurcate between hospital disinfectants with high-level efficacy requirements and medical device coatings that require biocompatible adhesion and controlled release. Household cleaners differentiate laundry additive formulations optimized for fabric safety and surface cleaners engineered for residue-free performance. Personal care applications cover a spectrum from antimicrobial soaps to deodorants and oral care products, each with unique sensory and regulatory constraints. Water treatment needs split between drinking water applications requiring trace-level safety and wastewater treatment where broader robustness against microbial loads is prioritized.

When viewed by type, natural extracts such as essential oils and plant extracts are being engineered for consistent potency, with subtypes like tea tree oil, thyme oil, and grapefruit seed extract increasingly standardized. Organic acids such as benzoic, propionic, and sorbic acids offer preservative function with established safety profiles, while phenolic compounds like orthophenylphenol present strong surface activity but face regulatory scrutiny in some jurisdictions. Quaternary ammonium compounds remain foundational for many disinfectant applications, with benzalkonium chloride and didecyldimethylammonium chloride as prevalent subtypes, and silver-based actives including colloidal silver and silver zeolite are advancing in coatings and medical device technologies.

Form-driven differentiation matters: foam formats-both aerosol and non-aerosol-provide user-friendly delivery for hand and surface products; gel systems, whether standard or thixotropic, support controlled application; liquid forms such as aqueous solutions and emulsions underpin many disinfectants and preservatives; powders in granules or microcapsules enable long-term storage stability and targeted release. Functional segmentation clarifies end-use design: coatings, whether industrial or for medical devices, demand durability and compatibility; disinfectants require instrument-level and surface efficacy; preservatives must balance cosmetic and food safety constraints; and sanitizers emphasize rapid, broad-spectrum activity suitable for hands or surfaces. Finally, source considerations-natural versus synthetic-drive procurement and branding decisions, with microbial fermentation derivatives like bacteriocins and enzymatic extracts competing with bio-based synthetics and petrochemical-derived actives on cost, sustainability, and regulatory acceptance. Together, these layered segmentation perspectives inform formulation trade-offs, supply chain sourcing, and regulatory strategies that companies must reconcile when prioritizing product pipelines and commercialization pathways.

Region-specific dynamics and strategic imperatives that influence regulatory compliance, supply chain design, and commercialization pathways across global geographies

Regional dynamics are shaping demand composition, regulatory priorities, and innovation ecosystems across the global antimicrobial ingredients landscape. In the Americas, commercial activity is driven by strong institutional demand from healthcare and a mature consumer market that expects sustainability credentials and regulatory transparency. This environment encourages suppliers to emphasize validated safety data and scalable manufacturing practices, while buyers seek suppliers with robust quality systems and domestic or nearshore production to reduce logistical risk.

In Europe, the Middle East and Africa region, regulatory rigor and public procurement standards drive adoption cycles, with an emphasis on harmonized safety assessments and restrictions on certain legacy chemistries. This regulatory posture, coupled with accelerating interest in bio-based and low-toxicity alternatives, is fueling partnerships between ingredient innovators and local formulators. In the Asia-Pacific region, high-volume manufacturing capacity, diverse application demand across agriculture, personal care, and water treatment, and variable regulatory regimes create both fast adoption pathways and complex compliance requirements. As a result, companies operating across regions must tailor formulation profiles, regulatory strategies, and commercial approaches to align with local certification expectations, distribution models, and end-user preferences. Coordinated regional strategies that balance central R&D with localized compliance and marketing will be essential for scaling successful product introductions.

Key attributes and strategic moves that distinguish leading companies in antimicrobial ingredients, from formulation innovation to supply chain resilience and regulatory excellence

Industry leadership in antimicrobial ingredients increasingly rests on the ability to combine technical differentiation, regulatory expertise, and agile manufacturing. Leading companies are investing in advanced formulation platforms, expanding capabilities in natural extract standardization, and scaling encapsulation and controlled-release technologies to deliver sustained antimicrobial performance. These investments are often complemented by strategic collaborations with contract manufacturers and specialty formulators to bridge capability gaps and accelerate market entry for novel actives.

High-performing players also prioritize transparent safety dossiers and third-party validation to ease regulatory review and gain buyer confidence, particularly for healthcare and food-contact applications. Operational excellence in supply chain management-such as diversification of raw material sources and qualification of backup suppliers-has become a competitive advantage, reducing the operational impact of trade disruptions. Furthermore, top-tier companies are leveraging sustainability metrics and life-cycle assessments to support product claims and satisfy increasingly scrutinizing procurement teams. Collectively, these capabilities define a profile of companies that can sustain innovation cycles, maintain compliance across multiple jurisdictions, and respond rapidly to shifts in end-user demands.

Actionable recommendations for leaders to align innovation, regulatory preparedness, and supply chain strategies to accelerate commercialization and build resilience

Industry leaders should adopt a multifaceted approach that aligns R&D priorities with regulatory foresight and commercial agility to capture emerging opportunities. First, prioritizing chemistries and delivery systems that balance efficacy with demonstrable safety and environmental credentials will reduce downstream reformulation risk and support broader market acceptance. Second, investing in supplier diversification and nearshoring options will mitigate exposure to policy-driven trade disruptions while enabling faster response times for critical applications. Third, building robust regulatory intelligence capabilities and engaging early with authorities can shorten approval cycles and preempt compliance obstacles.

In parallel, companies should pursue strategic partnerships with contract manufacturers and application specialists to accelerate scale-up and commercialization. Cross-functional collaboration between formulation scientists, regulatory affairs, and commercial teams will ensure that product profiles meet end-user constraints and procurement expectations. Finally, embedding sustainability metrics and transparent performance validation into product communications will strengthen brand trust and open procurement pathways with institutional buyers. These actions, taken together, create a pragmatic roadmap for enhancing resilience, accelerating time-to-market, and future-proofing product portfolios against evolving regulatory and customer demands.

Methodology overview explaining how primary interviews, technical literature synthesis, and supply chain analysis were integrated to ensure rigorous, practitioner-informed findings

This research synthesis draws on a layered methodology that integrates primary interviews, technical literature review, and cross-sector trend analysis to produce a holistic view of antimicrobial ingredient dynamics. Primary inputs were collected through structured interviews with formulation scientists, procurement executives, regulatory affairs specialists, and manufacturing leaders to capture practical insights into development priorities, sourcing constraints, and compliance practices. These qualitative inputs were triangulated with authoritative technical publications, safety assessments, and standards guidance to ensure factual accuracy and technical depth.

Analytic rigor was applied through thematic coding of interview data, comparative evaluation of formulation and delivery technologies, and assessment of regulatory trajectories across major jurisdictions. Supply chain analysis was informed by documented trade patterns, publicly available tariff schedules, and observed industry responses to policy shifts. Throughout the process, emphasis was placed on defensible interpretation rather than quantitative prognostication, enabling the report to offer prescriptive strategic guidance while avoiding speculative numeric projections. This methodology ensures the findings are grounded in practitioner experience, technical evidence, and observed market behaviors that together inform practical decision-making.

Concluding synthesis that ties technological, regulatory, and supply chain themes together to outline strategic imperatives for sustained competitive advantage

In summary, the antimicrobial ingredients sector is at an inflection point where technological innovation, regulatory evolution, and geopolitical considerations are collectively shaping product development and procurement strategies. Organizations that proactively prioritize safe, sustainable chemistries, diversify supply chains, and align cross-functional teams will be best positioned to respond to shifting end-use requirements. Strategic investments in encapsulation, controlled-release formats, and standardized natural extract production can yield competitive differentiation, while robust regulatory engagement reduces time-to-compliance for critical applications.

Moreover, the current trade and tariff environment underscores the importance of supply chain agility and contract flexibility. By integrating scenario planning, supplier qualification, and localized manufacturing options into strategic roadmaps, companies can reduce vulnerability to policy shocks and maintain continuity for essential product lines. Ultimately, firms that balance innovation with operational discipline and transparent safety validation will capture more durable value and sustain trust with demanding institutional buyers and consumers alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for multifunctional antimicrobial peptides in cosmetic formulations to combat skin pathogens
  • 5.2. Integration of silver nanoparticles in advanced wound dressing materials for sustained antimicrobial efficacy
  • 5.3. Utilization of natural plant-derived antimicrobials as alternatives to synthetic preservatives in food packaging
  • 5.4. Development of biofilm-resistant antimicrobial coatings for high-touch medical devices and equipment
  • 5.5. Emerging regulations driving the adoption of non-triazole antifungals in household cleaning products
  • 5.6. Innovations in enzyme-based antimicrobial solutions targeting antibiotic-resistant bacteria in agriculture

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Antimicrobial Ingredients Market, by Application

  • 8.1. Agriculture
    • 8.1.1. Animal Feed Additives
    • 8.1.2. Crop Protection
  • 8.2. Food And Beverage
    • 8.2.1. Food Preservation
    • 8.2.2. Surface Sanitation
  • 8.3. Healthcare
    • 8.3.1. Hospital Disinfectants
    • 8.3.2. Medical Device Coatings
  • 8.4. Household Cleaners
    • 8.4.1. Laundry Additives
    • 8.4.2. Surface Cleaners
  • 8.5. Personal Care
    • 8.5.1. Antimicrobial Soap
    • 8.5.2. Deodorants
    • 8.5.3. Oral Care
  • 8.6. Water Treatment
    • 8.6.1. Drinking Water
    • 8.6.2. Wastewater Treatment

9. Antimicrobial Ingredients Market, by Type

  • 9.1. Natural Extracts
    • 9.1.1. Essential Oils
      • 9.1.1.1. Tea Tree Oil
      • 9.1.1.2. Thyme Oil
    • 9.1.2. Plant Extracts
      • 9.1.2.1. Grapefruit Seed Extract
  • 9.2. Organic Acids
    • 9.2.1. Benzoic Acid
    • 9.2.2. Propionic Acid
    • 9.2.3. Sorbic Acid
  • 9.3. Phenolic Compounds
    • 9.3.1. Orthophenylphenol
    • 9.3.2. Triclosan
  • 9.4. Quaternary Ammonium Compounds
    • 9.4.1. Benzalkonium Chloride
    • 9.4.2. Didecyldimethylammonium Chloride
  • 9.5. Silver Based
    • 9.5.1. Colloidal Silver
    • 9.5.2. Silver Zeolite

10. Antimicrobial Ingredients Market, by Form

  • 10.1. Foam
    • 10.1.1. Aerosol Foam
    • 10.1.2. Non Aerosol Foam
  • 10.2. Gel
    • 10.2.1. Standard Gel
    • 10.2.2. Thixotropic Gel
  • 10.3. Liquid
    • 10.3.1. Aqueous Solution
    • 10.3.2. Emulsion
  • 10.4. Powder
    • 10.4.1. Granules
    • 10.4.2. Microcapsules

11. Antimicrobial Ingredients Market, by Function

  • 11.1. Coating
    • 11.1.1. Industrial Coating
    • 11.1.2. Medical Device Coating
  • 11.2. Disinfectant
    • 11.2.1. Instrument Disinfectant
    • 11.2.2. Surface Disinfectant
  • 11.3. Preservative
    • 11.3.1. Cosmetic Preservative
    • 11.3.2. Food Preservative
  • 11.4. Sanitizer
    • 11.4.1. Hand Sanitizer
    • 11.4.2. Surface Sanitizer

12. Antimicrobial Ingredients Market, by Source

  • 12.1. Natural
    • 12.1.1. Microbial Fermentation
      • 12.1.1.1. Bacteriocins
      • 12.1.1.2. Enzymatic Extracts
    • 12.1.2. Plant Based
  • 12.2. Synthetic
    • 12.2.1. Bio Based Synthetic
    • 12.2.2. Petrochemical Derived

13. Antimicrobial Ingredients Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Antimicrobial Ingredients Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Antimicrobial Ingredients Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Lonza Group AG
    • 16.3.2. BASF SE
    • 16.3.3. Dow Inc.
    • 16.3.4. Evonik Industries AG
    • 16.3.5. Solvay S.A.
    • 16.3.6. DuPont de Nemours, Inc.
    • 16.3.7. LANXESS AG
    • 16.3.8. Clariant AG
    • 16.3.9. Arkema S.A.
    • 16.3.10. Ashland Global Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FUNCTION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THIXOTROPI